Skip to main content
Log in

Pricing of orphan drugs a balancing act: profits vs patients

  • News item
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Reference

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Pricing of orphan drugs a balancing act: profits vs patients. PharmacoEcon Outcomes News 689, 3 (2013). https://doi.org/10.1007/s40274-013-0777-8

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-013-0777-8

Navigation